MMDRP:使用多模式深度学习预测药物反应和生物标志物发现
Farzan Taj1,2, Lincoln D Stein1,2
1Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A1, Canada.
Bioinformatics advances
|February 19, 2024
概括
这项研究引入了一种新的算法,通过整合多样化的细胞系数据和增强化学化合物表示来改善癌症中药物反应预测 (DRP),从而为临床应用带来更好的模型通用性.
科学领域:
- 药物基因组学 药物基因组学
- 计算生物学 计算生物学
- 癌症研究 癌症研究
背景情况:
- 由于分子差异,患者对癌症药物的反应有很大差异.
- 药物基因组学旨在将基因组变异与药物反应联系起来.
- 目前的药物反应预测 (DRP) 模型在一般化方面扎.
研究的目的:
- 为改进药物反应预测 (DRP) 开发一种新的算法.
- 解决当前DRP方法的局限性,包括数据集成和表示.
主要方法:
- 结合多个细胞系表征数据.
- 解决了药物反应数据的偏差.
- 改进了化学化合物表示.
主要成果:
- 为DRP开发了一个新的算法.
- 与现有方法相比,新算法显示了更好的概括性.
- 该算法集成了多omics数据和先进的化学表示.
结论:
- 这种新的算法提供了一种有希望的方法来提高DRP的准确性.
- 改进的DRP可以促进个性化癌症治疗.
- 开源实现促进了更广泛的采用和进一步的研究.
更多相关视频
相关概念视频
Analysis of Population Pharmacokinetic Data
256
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
256
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K


